SIML Simlatus Corp

Proscere Bioscience Announces $175M Distribution Agreement

Proscere Bioscience Announces $175M Distribution Agreement

SAN FRANCISCO, CA, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), the company announces that its Cannabis Division, Proscere Bioscience, has signed a 5-year distribution agreement with United Opportunities, LLC in value of $175M to sell its Cold-Water Cannabis/Hemp Extraction Systems in Europe and Canada.

On March 29, 2019, the Board of Directors approved the Company and its subsidiary, Proscere Bioscience Inc., to enter into a Distribution Agreement with United Opportunities, LLC allowing the rights to sell the Cold-Water Cannabis/Hemp Extraction Systems within all of Canada and Europe. The term of the agreement is for five years with guaranteed minimal purchase orders of $35,000,000 per year and/or $175,000,000 over a five year period.

Shawn Illingworth is the Managing Partner of United Opportunities, LLC, and the company was formed in 2017 in overseeing the purchases of multiple cannabis farms in the Humboldt, Adelanto, Needles, Nipton, Cal City, and Searchlight areas of California and Nevada. The company currently cultivates medical grade crops on a grand scale and supply product to all the major manufacturers and extraction companies in the industry.  Future plans are to expand the company and distribute internationally through attaining cultivation centers in Canada, Europe and Australia. United Opportunities is currently opening an office and showroom in Las Vegas, NV which will round out its current operating platforms in New York, Florida, and San Diego, California.

Proscere Bioscience manufactures and distributes a proprietary commercial Cold-Water Cannabis/Hemp Extraction Systems. This advanced method and technology is highly effective in producing medical-grade product used to help people suffering with a wide range of ailments; from treating pain, inflammation, infections, sleep issues and mood disorders. The CBD is also proven to support the immune system, protects the brain and . Proscere Bioscience’s commercial Cold-Water Cannabis/Hemp Extraction Systems are expected to yield $225M over the next 5 years, based upon expected growth and application. 

Safe Harbor for Forward-Looking Statements: his news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Contact:
Richard Hylen, CEO
Tel: (530) 205-3437
EN
09/04/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Simlatus Corp

 PRESS RELEASE

SIML Proscere Bioscience Receives $16M CBD Order on New Hybrid System

SIML Proscere Bioscience Receives $16M CBD Order on New Hybrid System SAN FRANCISCO, CA, Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), a holding company currently focused on opportunities in the cannabis space that owns and operates a number of subsidiaries, all with multiple revenue streams, diversified in cannabis processing products, commercial broadcasting and support services to AT&T’s DirecTV products. Today the company announces that it has received another purchase order from United Opportunities LLC on ...

 PRESS RELEASE

SIML Proscere Bioscience Positions Long Term Strategy

SIML Proscere Bioscience Positions Long Term Strategy San Francisco, California, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry. In addition, the company’s diver...

 PRESS RELEASE

SIML Proscere Bioscience Waltzing With Largest Cannabis Processor

SIML Proscere Bioscience Waltzing With Largest Cannabis Processor San Francisco, California, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry. In addition, the com...

 PRESS RELEASE

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD...

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD/Hemp Extraction Systems from Brand House Ventures Inc. San Francisco, California, July 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’...

 PRESS RELEASE

SIML Drives-Down Debt and Increases Profits From the $50B Cannabis Ind...

SIML Drives-Down Debt and Increases Profits From the $50B Cannabis Industry With NASDAQ on the Horizon San Francisco, California, July 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on t...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch